These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 15795119)

  • 1. Immunohistochemical characterization of cutaneous drug eruptions by STI571.
    Park HJ; Kim HS; Kim HJ; Lee JY; Cho BK; Lee AW; Yoon DY; Cho DH
    J Dermatol Sci; 2005 Apr; 38(1):9-15. PubMed ID: 15795119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triptolide inhibits Bcr-Abl transcription and induces apoptosis in STI571-resistant chronic myelogenous leukemia cells harboring T315I mutation.
    Shi X; Jin Y; Cheng C; Zhang H; Zou W; Zheng Q; Lu Z; Chen Q; Lai Y; Pan J
    Clin Cancer Res; 2009 Mar; 15(5):1686-97. PubMed ID: 19240172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell involvement in drug-induced acute generalized exanthematous pustulosis.
    Britschgi M; Steiner UC; Schmid S; Depta JP; Senti G; Bircher A; Burkhart C; Yawalkar N; Pichler WJ
    J Clin Invest; 2001 Jun; 107(11):1433-41. PubMed ID: 11390425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased drug reactions in HIV-1-positive patients: a possible explanation based on patterns of immune dysregulation seen in HIV-1 disease. The Military Medical Consortium for the Advancement of Retroviral Research (MMCARR).
    Smith KJ; Skelton HG; Yeager J; Ledsky R; Ng TH; Wagner KF
    Clin Exp Dermatol; 1997 May; 22(3):118-23. PubMed ID: 9425690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced exanthems.
    Yawalkar N
    Toxicology; 2005 Apr; 209(2):131-4. PubMed ID: 15767025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imatinib mesylate (STI571) abrogates the resistance to doxorubicin in human K562 chronic myeloid leukemia cells by inhibition of BCR/ABL kinase-mediated DNA repair.
    Majsterek I; Sliwinski T; Poplawski T; Pytel D; Kowalski M; Slupianek A; Skorski T; Blasiak J
    Mutat Res; 2006 Jan; 603(1):74-82. PubMed ID: 16388976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of BCR-ABL gene mutations in Philadelphia chromosome positive leukemia patients resistant to STI-571 cancer therapy.
    Chien JH; Tang JL; Chen RL; Li CC; Lee CP
    Leuk Res; 2008 Nov; 32(11):1724-34. PubMed ID: 18603297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Livedoid skin reaction probably due to imatinib therapy.
    Martínez-González MC; del Pozo J; Yebra-Pimentel MT; Pérez M; Almagro M; Fonseca E
    Ann Pharmacother; 2007 Jan; 41(1):148-52. PubMed ID: 17190842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow changes in chronic myelogenous leukaemia after long-term treatment with the tyrosine kinase inhibitor STI571: an immunohistochemical study on 75 patients.
    Thiele J; Kvasnicka HM; Schmitt-Graeff A; Kriener S; Engels K; Staib P; Ollig ES; Keller C; Fokkema S; Griesshammer M; Waller CF; Ottmann OG; Hansmann ML
    Histopathology; 2005 May; 46(5):540-50. PubMed ID: 15842636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral and cutaneous lichenoid reaction with nail changes secondary to imatinib: report of a case and literature review.
    Wahiduzzaman M; Pubalan M
    Dermatol Online J; 2008 Dec; 14(12):14. PubMed ID: 19265627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine and chemokine expression in the skin from patients with maculopapular exanthema to drugs.
    Fernandez TD; Mayorga C; Torres MJ; Cornejo-Garcia JA; López S; Chaves P; Rondon C; Blanca M
    Allergy; 2008 Jun; 63(6):712-9. PubMed ID: 18384452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus.
    Popovic K; Ek M; Espinosa A; Padyukov L; Harris HE; Wahren-Herlenius M; Nyberg F
    Arthritis Rheum; 2005 Nov; 52(11):3639-45. PubMed ID: 16255056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Usefulness of skin testing in cutaneous drug eruptions in routine practice.
    Tchen T; Reguiaï Z; Vitry F; Arnoult E; Grange A; Florent G; Bernard P
    Contact Dermatitis; 2009 Sep; 61(3):138-44. PubMed ID: 19780771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-immediate reactions to beta-lactams: diagnostic value of skin testing and drug provocation test.
    Padial A; Antunez C; Blanca-Lopez N; Fernandez TD; Cornejo-Garcia JA; Mayorga C; Torres MJ; Blanca M
    Clin Exp Allergy; 2008 May; 38(5):822-8. PubMed ID: 18331363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of phosphotyrosine phosphatase 1B causes resistance in BCR-ABL-positive leukemia cells to the ABL kinase inhibitor STI571.
    Koyama N; Koschmieder S; Tyagi S; Portero-Robles I; Chromic J; Myloch S; Nürnberger H; Rossmanith T; Hofmann WK; Hoelzer D; Ottmann OG
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2025-31. PubMed ID: 16609011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro interleukin-5 (IL-5) production by peripheral blood mononuclear cells from patients with drug hypersensitivity.
    Mikami C; Ochiai K; Kagami M; Tomioka H; Tanabe E
    J Dermatol; 1996 Jun; 23(6):379-81. PubMed ID: 8708148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heliotrope-like eruption mimicking dermatomyositis in a patient treated with imatinib mesylate for chronic myeloid leukemia.
    Kuwano Y; Asahina A; Watanabe R; Fujimoto M; Ihn H; Tamaki K
    Int J Dermatol; 2006 Oct; 45(10):1249-51. PubMed ID: 17040457
    [No Abstract]   [Full Text] [Related]  

  • 18. T cell populations propagating in the peripheral blood of patients with drug eruptions.
    Nishio D; Izu K; Kabashima K; Tokura Y
    J Dermatol Sci; 2007 Oct; 48(1):25-33. PubMed ID: 17601705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follicular acneiform eruption induced by imatinib.
    Martín JM; Jordá E; Monteagudo C; Alonso V; García L; Villalón G
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1368-70. PubMed ID: 17062082
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug eruptions at five institutes in Bangkok.
    Puavilai S; Noppakun N; Sitakalin C; Leenutaphong V; Wattanakrai P; Nakakes A; Kulthanan K; Asawanonda P; Akaraphan R; Tresukosol P; Suthipinittharm P; Somburanasin P; Charuwichitratana S; Rajatanavin N
    J Med Assoc Thai; 2005 Nov; 88(11):1642-50. PubMed ID: 16471114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.